Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Single-agent and combination biologics in acute myeloid leukemia

Guillaume Richard-Carpentier, Courtney D. DiNardo

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 548–556.

https://doi.org/10.1182/hematology.2019000059

Published: 2019

Journal Articles

Molecular profiling and management of mantle cell lymphoma

Jia Ruan

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 30–40.

https://doi.org/10.1182/hematology.2019000011

Published: 2019

Journal Articles

Cytotoxic therapy in acute myeloid leukemia: not quite dead yet

Laura C. Michaelis

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 51–62.

https://doi.org/10.1182/asheducation-2018.1.51

Published: 2018

Journal Articles

Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents

Andrés José María Ferreri

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 565–577.

https://doi.org/10.1182/asheducation-2017.1.565

Published: 2017

Journal Articles

Optimizing therapy for mantle cell lymphoma

Peter Martin

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 304–309.

https://doi.org/10.1182/asheducation-2017.1.304

Published: 2017

Journal Articles

The role of targeted therapy in the management of patients with AML

Alexander E. Perl

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 54–65.

https://doi.org/10.1182/asheducation-2017.1.54

Published: 2017

Journal Articles

Frontline therapy and role of high-dose consolidation in mantle cell lymphoma

Simon Rule

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 419–424.

https://doi.org/10.1182/asheducation-2016.1.419

Published: 2016

Journal Articles

Acute myeloid leukemia in children and adolescents: identification of new molecular targets brings promise of new therapies

E. Anders Kolb, Soheil Meshinchi

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 507–513.

https://doi.org/10.1182/asheducation-2015.1.507

Published: 2015

Journal Articles

Intermediate-risk acute myeloid leukemia therapy: current and future

Konstanze Döhner, Peter Paschka

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 34–43.

https://doi.org/10.1182/asheducation.V2014.1.34.3882398

Published: 2014

Journal Articles

Treating acute myeloid leukemia in older adults

Eunice S. Wang

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 14–20.

https://doi.org/10.1182/asheducation-2014.1.14

Published: 2014

Journal Articles

Transplantation for mantle cell lymphoma: is it the right thing to do?

Michael E. Williams

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 568–574.

https://doi.org/10.1182/asheducation-2013.1.568

Published: 2013

Journal Articles

High-risk acute myelogenous leukemia: treatment today … and tomorrow

Gary J. Schiller

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 201–208.

https://doi.org/10.1182/asheducation-2013.1.201

Published: 2013

Journal Articles

Core-binding factor acute myeloid leukemia: can we improve on HiDAC consolidation?

Peter Paschka, Konstanze Döhner

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 209–219.

https://doi.org/10.1182/asheducation-2013.1.209

Published: 2013

Journal Articles

Treatment of acute myeloid leukemia: are we making progress?

Alan K. Burnett

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 1–6.

https://doi.org/10.1182/asheducation.V2012.1.1.3797038

Published: 2012

Journal Articles

Novel Approaches to the Treatment of Acute Myeloid Leukemia

Gail J. Roboz

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 43–50.

https://doi.org/10.1182/asheducation-2011.1.43

Published: 2011

Journal Articles

New Trends in the Standard of Care for Initial Therapy of Acute Myeloid Leukemia

Hugo F. Fernandez

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 56–61.

https://doi.org/10.1182/asheducation-2010.1.56

Published: 2010

Journal Articles

Curative Strategies in Acute Promyelocytic Leukemia

Martin S. Tallman, Jessica K. Altman

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 391–399.

https://doi.org/10.1182/asheducation-2008.1.391

Published: 2008

Journal Articles

Prognostic Factors in Elderly Patients with AML and the Implications for Treatment

Harry P. Erba

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 420–428.

https://doi.org/10.1182/asheducation-2007.1.420

Published: 2007

Journal Articles

New Strategies for the Treatment of Acute Myeloid Leukemia Including Antibodies and Other Novel Agents

Martin S. Tallman

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 143–150.

https://doi.org/10.1182/asheducation-2005.1.143

Published: 2005

Journal Articles

Acute Myeloid Leukemia

Richard M. Stone, Margaret R. O'Donnell, Mikkael A. Sekeres

Hematology Am Soc Hematol Educ Program (2004) 2004 (1): 98–117.

https://doi.org/10.1182/asheducation-2004.1.98

Published: 2004

NARROW

Single-agent and combination biologics in acute myeloid leukemia

Molecular profiling and management of mantle cell lymphoma

Cytotoxic therapy in acute myeloid leukemia: not quite dead yet

Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents

Optimizing therapy for mantle cell lymphoma

The role of targeted therapy in the management of patients with AML

Frontline therapy and role of high-dose consolidation in mantle cell lymphoma

Acute myeloid leukemia in children and adolescents: identification of new molecular targets brings promise of new therapies

Intermediate-risk acute myeloid leukemia therapy: current and future

Treating acute myeloid leukemia in older adults

Transplantation for mantle cell lymphoma: is it the right thing to do?

High-risk acute myelogenous leukemia: treatment today … and tomorrow

Core-binding factor acute myeloid leukemia: can we improve on HiDAC consolidation?

Treatment of acute myeloid leukemia: are we making progress?

Novel Approaches to the Treatment of Acute Myeloid Leukemia

New Trends in the Standard of Care for Initial Therapy of Acute Myeloid Leukemia

Curative Strategies in Acute Promyelocytic Leukemia

Prognostic Factors in Elderly Patients with AML and the Implications for Treatment

New Strategies for the Treatment of Acute Myeloid Leukemia Including Antibodies and Other Novel Agents

Acute Myeloid Leukemia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only